Gene symbol | CD22 | Synonyms | SIGLEC-2, SIGLEC2 | Type of gene | protein-coding | |
Chromosome | 19 | Map location | 19q13.12 | dbXrefs | Entrez:933 MIM:107266 HGNC:HGNC:1643 Ensembl:ENSG00000012124 AllianceGenome:HGNC:1643 | |
Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | |||||
Description | CD22 molecule |
GTO ID | GTC0747 |
Trial ID | ChiCTR1800017402 |
Disease | Hematologic Cancer |
Altered gene | CD22 |
Therapeutic/Target gene | Target gene |
Therapy | CAR-T cell |
Treatment | CD22 CAR-T cells |
Phase | Phase1 |
Recruitment status | Recruiting |
Title | Clinical and basic research of CD22-CAR T cells in the treatment of hematologic malignancy |
Year | 2018 |
Country | China |
Company sponsor | the First Affiliated Hospital of Zhejiang University School of Medicine |
Cohort 1 | |||||
|